ÖZDEMİR, Ö. 2012. Silan C, Dogan OT, Silan F, Kukulgüven FM, Asgün HF, Ozdemir S, Uludag A, Atik S, Gungor B, Akdur S, Aksulu HE, Ozdemir O. The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population.. Mol Biol Rep. , vol.39 (12) , 17-22.

ÖZDEMİR, Ö., (2012). Silan C, Dogan OT, Silan F, Kukulgüven FM, Asgün HF, Ozdemir S, Uludag A, Atik S, Gungor B, Akdur S, Aksulu HE, Ozdemir O. The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population.. Mol Biol Rep. , vol.39 (12), 17-22.

ÖZDEMİR, ÖZTÜRK. "Silan C, Dogan OT, Silan F, Kukulgüven FM, Asgün HF, Ozdemir S, Uludag A, Atik S, Gungor B, Akdur S, Aksulu HE, Ozdemir O. The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population.," Mol Biol Rep. , vol.39 (12), 17-22, 2012

ÖZDEMİR, ÖZTÜRK. "Silan C, Dogan OT, Silan F, Kukulgüven FM, Asgün HF, Ozdemir S, Uludag A, Atik S, Gungor B, Akdur S, Aksulu HE, Ozdemir O. The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population.." Mol Biol Rep. , vol.39 (12), pp.17-22, 2012

ÖZDEMİR, Ö. (2012) . "Silan C, Dogan OT, Silan F, Kukulgüven FM, Asgün HF, Ozdemir S, Uludag A, Atik S, Gungor B, Akdur S, Aksulu HE, Ozdemir O. The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population.." Mol Biol Rep. , vol.39 (12), pp.17-22.

@article{article, author={ÖZTÜRK ÖZDEMİR}, title={Silan C, Dogan OT, Silan F, Kukulgüven FM, Asgün HF, Ozdemir S, Uludag A, Atik S, Gungor B, Akdur S, Aksulu HE, Ozdemir O. The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population.}, journal={Mol Biol Rep.}, year=2012, pages={17-22} }